Dr. Huynh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
455 S Main St
Orange, CA 92868Phone+1 714-516-4348Fax+1 714-532-8699
Summary
- Dr. Van Huynh is a pediatric hematologist/oncologist in Orange, CA and is affiliated with Children's Hospital of Orange County. She received her medical degree from University of California Irvine School of Medicine and has been in practice 9 years. She also speaks multiple languages, including Vietnamese. She specializes in pediatric oncology.
Education & Training
- University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 2004 - 2007
- University of California, Irvine, School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2005 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- Hematology/OncologyHematology/Oncology
Awards, Honors, & Recognition
- PSF Tithe Award "A pilot Study of asparaginase level drug monitoring in pediatric leukemia patients, 2016
Clinical Trials
- PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Start of enrollment: 2019 Feb 12
- Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia Start of enrollment: 2023 Mar 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Reducing Learning and Psychosocial Disparities in Latino Children with Cancer: A Randomized Intervention Trial.Sunita K Patel, Seong-Hyeon Kim, Kathleen Ingman, Van Huynh, Heather Huszti
Journal of the National Cancer Institute. 2024-10-16 - 17 citationsThree-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.Alan S Wayne, Van Huynh, Nobuko Hijiya, Rayne H Rouce, Patrick A Brown
Haematologica. 2023-03-01 - Mediport use as an acceptable standard for CAR T cell infusion.Maya Eylon, Snehit Prabhu, Samuel John, Maxwell J M King, Dhruv Bhatt
Frontiers in Immunology. 2023-01-01
Other Languages
- Vietnamese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: